CEPHEID
Cepheid is a molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.
CEPHEID
Industry:
Biotechnology Genetics Health Care Health Diagnostics Medical
Founded:
1996-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.cepheid.com
Total Employee:
1001+
Status:
Active
Contact:
4085416439
Total Funding:
117.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving Mobile Non Scaleable Content Nginx
Similar Organizations
Accelerate Diagnostics
Accelerate Diagnostics is an in vitro diagnostics company providing solutions to drug resistant organisms and hospital acquired infections.
AlliedPath
AlliedPath is a cancer-focused laboratory that offers solid tumor specific molecular tests to regional hospital and reference laboratories.
AltheaDx
AltheaDx offers molecular diagnostics and PCR-based services such as molecular biomarker discovery, assay development and assay validation.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
Neomorphics
Neomorphic uses software algorithms and computing infrastructure to analyze, assemble and annotate genomic and expressed gene sequence data.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Qiagen
QIAGEN provides technologies and products for preanalytical sample preparation and linked molecular assay solutions.
CareDx
CareDx is a novel molÂeÂcÂuÂlar diagnosÂtics comÂpany.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-16 | Oncomark | Oncomark acquired by Cepheid | N/A |
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Cepheid
U.S. Department of Health & Human Services
U.S. Department of Health & Human Services investment in Grant - Cepheid
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Cepheid
Wheatley Partners
Wheatley Partners investment in Series C - Cepheid
Innogenetics
Innogenetics investment in Series C - Cepheid
Official Site Inspections
http://www.cepheid.com Semrush global rank: 381.9 K Semrush visits lastest month: 148.96 K
- Host name: 199.232.107.10
- IP address: 199.232.107.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cepheid"
Cepheid (company) - Wikipedia
Cepheid [a] is an American molecular diagnostics company that is a wholly owned subsidiary of Danaher Corporation.Its systems automate traditional nucleic acid tests (tests for specific sequences of DNA or RNA).The tests can be used …See details»
Cepheid Org Chart + Executive Team - The Official Board
Feb 21, 2025 The org chart of Cepheid contains its 37 main executives like Vitor Rocha, Charles Mwangi and Sandra Wells.See details»
Cepheid - Crunchbase Company Profile & Funding
Cepheid is a molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to …See details»
Cepheid | Home
Cepheid's GeneXpert ® System is the world's most flexible platform, providing healthcare professionals with a best in class test menu for any setting — from the core lab to near patient applications. Find out why Cepheid's solutions are a …See details»
Cepheid Management Team | Org Chart - RocketReach
Cepheid employs 4,895 employees. The Cepheid management team includes John Bishop (Chairman and CEO), Traci Wicks (Senior Vice President, Cepheid Human Resources and …See details»
CEPHEID | Company Overview & News - Forbes
Cepheid operates as a molecular diagnostics company, which develops, manufactures, and markets fully-integrated systems for testing in the clinical market,See details»
Our Leadership - Cepheid
Our leadership team pushes us to deliver A Better Way to improve patient outcomes by enabling access to molecular diagnostic testing to patients everywhere.With diverse skills and a shared …See details»
Delivering a higher level of PCR excellence - stage …
Cepheid enables access to molecular diagnostic testing everywhere with the GeneXpert® system.See details»
Mission & History of Delivering PCR Excellence - Cepheid
Listed on the Nasdaq in 2000, Cepheid was acquired in 2016 by Danaher Corporation, a Fortune 150 life science and technology innovator. Cepheid is proud to be part of Danaher. Danaher’s science and technology leadership …See details»
Cepheid | Danaher
At Cepheid, our mission is to enable medical providers to identify and treat diseases early, increasing opportunities to improve patients’ survival and quality of life. We are a molecular diagnostics company dedicated to improving …See details»
Cepheid Announces Direct Commercial Operations in Canada
Oct 4, 2021 About Cepheid Based in Sunnyvale, Calif. , Cepheid is a leading molecular diagnostics company. Cepheid is dedicated to improving healthcare by developing, …See details»
Delivering a higher level of PCR excellence - Cepheid
About Cepheid. Cepheid’s GeneXpert ® systems and Xpert ® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to …See details»
Mission & History of Delivering PCR Excellence - cepheid.com
In 2010, the World Health Organization (WHO) endorsed Cepheid’s first tuberculosis test, Xpert® MTB/RIF as a major milestone 1 for TB and Multidrug-resistant-TB (MDR-TB) care delivery, …See details»
Enabling Access to Molecular Diagnostic Testing Everywhere
Apr 9, 2025 Cepheid's GeneXpert® System is a flexible, fully scalable platform that provides healthcare professionals with a broad test menu for any setting — from the core lab to near …See details»
Cepheid - Move from point-of-complexity to point-of-care simplicity
Come, discover how it’s Simpler with Cepheid. Point-of-care PCR testing needs to be simpler in order for you to deliver a quality care experience with results everyone can trust, now and in …See details»
Mission & History of Delivering PCR Excellence - dev …
Learn more about Cepheid’s Track Record of Innovation. Cepheid’s Company History Cepheid was founded in 1996 with a vision to develop an innovative system that simplified a highly …See details»
Cepheid | Enabling Access to Molecular Diagnostic Testing …
Cepheid's GeneXpert ® System is the world's most flexible platform, providing healthcare professionals with a best in class test menu for any setting — from the core lab to near patient …See details»
Cepheid
Cepheid processes your personal data to send you the requested information. You have rights regarding your personal data, and consent may be withdrawn at any time. For additional …See details»
Cepheid Receives Health Canada Licence for Xpert® HIV-1
21 hours ago About Cepheid Based in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is an operating company within Danaher Corporation's Diagnostics …See details»
Mission & History of Delivering PCR Excellence - stage …
Explore the Mission and History behind Cepheid’s innovative molecular diagnostic technology which improves patient outcomes everywhere.See details»